Clinical Trial Update: Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on treating autonomous hyperparathyroidism in post-renal transplant recipients; results completed with posted results in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allograft Nephropathy
• Chronic Kidney Disease
• Disordered Mineral Metabolism
• End-stage Renal Disease
• Hyperparathyroidism
• Kidney Disease
• Kidney Transplantation
• Post Renal Transplantation

Snippet

Sponsor: Amgen | Conditions: Chronic Allograft Nephropathy, Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2016-01-29